Jan Erik Berdal

445 total citations
10 papers, 207 citations indexed

About

Jan Erik Berdal is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Jan Erik Berdal has authored 10 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Jan Erik Berdal's work include COVID-19 Clinical Research Studies (2 papers), COVID-19 and healthcare impacts (2 papers) and vaccines and immunoinformatics approaches (1 paper). Jan Erik Berdal is often cited by papers focused on COVID-19 Clinical Research Studies (2 papers), COVID-19 and healthcare impacts (2 papers) and vaccines and immunoinformatics approaches (1 paper). Jan Erik Berdal collaborates with scholars based in Norway, United Kingdom and United States. Jan Erik Berdal's co-authors include Christine Monceyron Jonassen, Peder L. Myhre, Christian Prebensen, Torbjørn Omland, Andreas Rydning, Helge Røsjø, My Svensson, Anbjørg Rangberg, Signe Søvik and Ragnhild Røysland and has published in prestigious journals such as Circulation, PLoS ONE and American Heart Journal.

In The Last Decade

Jan Erik Berdal

10 papers receiving 205 citations

Peers

Jan Erik Berdal

EPIDE

NEURO

RHEUM

IMMUN

Sara Ghoneim United States

Christian Prebensen Norway

Ángeles Muñoz Spain

O. V. Zayrаtyants Russia

Tristan Legris France

Doaa Attia Egypt

Christos Gogos Greece

Eleni Palli Greece

P. Marks United Kingdom

О. В. Благова Russia

Sara Ghoneim United States

Jan Erik Berdal

92 ×1.1

110 ×1.9

EPIDE

18 ×0.4

NEURO

12 ×0.3

RHEUM

13 ×0.3

IMMUN

Citations per year, relative to Jan Erik Berdal Jan Erik Berdal (= 1×) peers Sara Ghoneim

Countries citing papers authored by Jan Erik Berdal

Since Specialization

Citations

This map shows the geographic impact of Jan Erik Berdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Erik Berdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Erik Berdal more than expected).

Fields of papers citing papers by Jan Erik Berdal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Erik Berdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Erik Berdal. The network helps show where Jan Erik Berdal may publish in the future.

Co-authorship network of co-authors of Jan Erik Berdal

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Erik Berdal. A scholar is included among the top collaborators of Jan Erik Berdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Erik Berdal. Jan Erik Berdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Berdal, Jan Erik, et al.. (2024). Impact of antibiotic therapy in patients with respiratory viral infections: a retrospective cohort study. Infectious Diseases. 56(12). 1031–1039. 1 indexed citations

Whitworth, Jimmy, et al.. (2023). Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing E. coli. Infectious Diseases. 56(1). 19–31. 6 indexed citations

Myhre, Peder L., Siri Lagethon Heck, Christian Prebensen, et al.. (2021). Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity. American Heart Journal. 242. 61–70. 23 indexed citations

Myhre, Peder L., Christian Prebensen, Christine Monceyron Jonassen, Jan Erik Berdal, & Torbjørn Omland. (2021). SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19. Journal of the American Heart Association. 10(9). e019756–e019756. 16 indexed citations

Whitworth, Jimmy, et al.. (2021). Comparison of SARS-CoV-2 infections in healthcare workers with high and low exposures to Covid-19 patients in a Norwegian University Hospital. Infectious Diseases. 53(6). 420–429. 5 indexed citations

Omland, Torbjørn, Christian Prebensen, Christine Monceyron Jonassen, et al.. (2021). Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19. Open Heart. 8(2). e001884–e001884. 13 indexed citations

Myhre, Peder L., Christian Prebensen, Ragnhild Røysland, et al.. (2020). Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19. Circulation. 142(22). 2128–2137. 77 indexed citations

Hesstvedt, Liv, Peter Gaustad, Fredrik Müller, et al.. (2019). The impact of age on risk assessment, therapeutic practice and outcome in candidemia. Infectious Diseases. 51(6). 425–434. 16 indexed citations

Mohn, Kristin G. I., Rebecca Jane Cox, Gro Tunheim, et al.. (2015). Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway. PLoS ONE. 10(11). e0143281–e0143281. 16 indexed citations

10.

Berdal, Jan Erik, et al.. (1998). [Incidence and prevalence of autoimmune liver diseases].. PubMed. 118(29). 4517–9. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact